Diffusion Pharmaceuticals Inc.
Diffusion Pharmaceuticals Inc. (DFFN) Stock Overview
Explore Diffusion Pharmaceuticals Inc.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
9M
P/E Ratio
0.00
EPS (TTM)
$-7.11
ROE
196.74%
DFFN Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Diffusion Pharmaceuticals Inc. (DFFN) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $2.42.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 0.00 and a market capitalization of 9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.